Grifols, S.A.

Equities

GRF

ES0171996087

Market Closed - BME Other stock markets 16:35:00 12/05/2026 BST			5-day change	1st Jan Change
8.700 ^EUR	-1.47%		-3.48%	-18.69%

05-11	European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading	MT
05-08	Grifols: FCFs didn't impress; rebuilding trust isn't going to be easy

Transcript : Grifols, S.A., 2025 Earnings Call, Feb 26, 2026

Published on 02/26/2026 at 07:05 pm GMT - Modified on 02/26/2026 at 10:20 pm GMT

S&P Capital IQ

Presenter Speech
Daniel Segarra (Executives)

Hello, everyone, and thank you for joining us today for Grifols' Fourth Quarter and Full Year 2025 Earnings Call. My name is Danny Segarra, and I serve as

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Grifols, S.A.

05-11	European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading	MT
05-08	Grifols: FCFs didn't impress; rebuilding trust isn't going to be easy
05-08	Moody's Changes Grifols Outlook to Positive	MT
05-08	Grifols Q1 Adjusted Profit Rises, Revenue Falls	MT
05-08	Spanish stocks - Factors to watch on May 8	RE
05-07	Grifols, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-07	Grifols, S.A., Q1 2026 Earnings Call, May 07, 2026
05-07	Grifols on track to deliver 2026 objectives	RE
05-04	European Equities Traded in the US as American Depositary Receipts Start Week Lower	MT
04-30	European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	MT
04-24	Grifols closes 29 plasma donation centers in US to optimise operations	RE
04-23	Spanish stocks - Factors to watch on April 23	RE
04-20	European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	MT
04-16	Grifols receives FDA approval for its malaria blood screening assay	RE
04-15	European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading	MT